Table 3. Prevalence of each Cardiovascular Risk Component (Prevalence + 95% CI).
| Younger Group | Older Group | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Heart Disease | Stroke | Heart Disease | Stroke | Diabetes | SBP≥160 | ||||
| Crude | Men | N=6,910 | 1.4 (1.1-1.7) | 0.6 (0.5-0.8) | N=10,269 | 4.6 (4.2-5.0) | 4.0 (3.7-4.4) | 12.3 (11.7-12.9) | 13.6 (13.0-14.3) |
| Overall | Women | N=13,176 | 2.8 (2.6-3.1) | 1.1 (0.9-1.3) | N=6,712 | 5.5 (5.0-6.1) | 4.1 (3.7-4.6) | 17.5 (16.6-18.4) | 20.5 (20.0-21.5) |
| Standardized | Men | N=6,910 | 1.4 (1.1-1.7) | 0.6 (0.5-0.8) | N=10,269 | 4.6 (4.2-5.1) | 4.2 (3.8-4.6) | 12.2 (11.5-12.9) | 14.1 (13.3-14.8) |
| Overall | Women | N=13,176 | 3.0 (2.7-3.3) | 1.1 (1.0-1.3) | N=6,712 | 6.0 (5.3-6.8) | 4.3 (3.8-4.9) | 18.1 (17.0-19.3) | 23.2 (21.9-24.5) |
|
| |||||||||
| South Africa | Men | N=134 | 1.5 (0.4-5.5) | 1.0 (0.2-6.0) | N=115 | 7.2 (3.9-12.7) | 7.3 (4.3-12.1) | 9.6 (5.8-15.5) | 27.2 (20.0-35.9) |
| Women | N=358 | 4.9 (3.0-8.6) | 5.0 (2.8-8.6) | N=84 | 12.9 (7.9-20.3) | 1.8 (0.5-6.4) | 25.0 (18.8-32.5) | 25.4 (18.6-33.6) | |
| Bangladesh | Men | N=618 | 8.6 (6.5-11.3) | 2.6 (1.6-4.0) | N=1,097 | 12.9 (10.9-15.1) | 7.0 (5.6-8.8) | 12.8 (10.9-14.9) | 8.1 (6.6-9.8) |
| Women | N=1,606 | 14.0 (12.4-15.8) | 4.0 (3.1-5.1) | N=435 | 14.6 (12.0-17.7) | 7.0 (4.9-9.8) | 19.0 (15.6-22.9) | 18.1 (14.8-21.9) | |
| China | Men | N=234 | 0.4 (0.1-2.4) | 1.4 (0.4-4.3) | N=2,276 | 4.2 (3.4-5.2) | 8.6 (7.5-9.9) | 8.3 (7.3-9.5) | 22.2 (20.5-23.9) |
| Women | N=466 | 3.6 (2.4-5.3) | 1.8 (1.0-3.6) | N=2,317 | 7.3 (6.3-8.4) | 7.5 (6.4-8.6) | 20.3 (18.6-22.0) | 31.8 (29.9-33.8) | |
| India, New Delhi | Men | N=1,741 | 0.6 (0.3-1.3) | 0.4 (0.2-1.0) | N=1,314 | 4.2 (2.9-6.1) | 1.9 (1.3-2.8) | 26.0 (21.7-30.7) | 14.7 (13.0-16.4) |
| Women | N=2,704 | 0.6 (0.2-1.4) | 4.6 (0.2-1.0) | N=540 | 4.4 (2.9-6.5) | 1.0 (0.5-2.0) | 39.3 (33.5-45.4) | 22.8 (16.9-30.0) | |
| India, Bangalore | Men | N=1,994 | 0.1 (0.0-0.4) | 0.0 (0.0-0.4) | N=2,138 | 0.2 (0.1-0.8) | 1.8 (1.1-2.9) | 7.0 (5.6-8.7) | 10.4 (8.7-12.3) |
| Women | N=3,217 | 0.2 (0.1-0.7) | 0.1 (0.0-0.3) | N=1,267 | 0.7 (0.2-3.4) | 0.8 (0.3-2.0) | 4.3 (3.1-6.0) | 19.8 (16.3-23.9) | |
| Pakistan | Men | N=593 | 1.0 (0.3-3.1) | 0.6 (0.2-1.8) | N=539 | 4.1 (2.6-6.3) | 1.8 (1.0-3.3) | 19.1 (15.3-23.5) | 12.2 (9.0-16.3) |
| Women | N=1,086 | 0.4 (0.1-1.0) | 1.0 (0.5-2.1) | N=162 | 0.4 (0.1-1.6) | 3.5 (1.3-9.0) | 28.7 (21.1-37.8) | 24.3 (16.2-34.8) | |
| Argentina | Men | N=545 | 0.6 (0.2-1.5) | 0.1 (0.0-1.0) | N=1,026 | 4.8 (3.6-6.4) | 1.6 (1.0-2.6) | 10.7 (8.7-13.1) | 12.2 (10.3-14.4) |
| Women | N=1,621 | 1.1 (0.6-1.7) | 0.6 (0.4-1.1) | N=749 | 2.3 (1.4-3.7) | 1.4 (0.7-2.6) | 13.8 (11.2-16.8) | 16.8 (14.3-19.7) | |
| Chile | Men | N=367 | 1.7 (0.8-3.7) | 1.0 (0.3-3.2) | N=552 | 4.3 (2.9-6.3) | 1.2 (0.6-2.5) | 15.1 (12.5-18.2) | 12.0 (9.5-15.0) |
| Women | N=662 | 1.3 (0.7-2.3) | 0.6 (0.3-1.5) | N=359 | 4.5 (2.6-7.7) | 1.3 (0.5-3.1) | 21.1 (17.1-25.8) | 16.1 (12.9-20.0) | |
| Peru | Men | N=447 | 1.6 (0.8-3.1) | 0.4 (0.1-1.7) | N=797 | 4.0 (2.9-5.6) | 0.7 (0.3-1.6) | 8.5 (6.7-10.6) | 3.8 (2.7-5.3) |
| Women | N=883 | 3.5 (2.5-4.8) | 0.5 (0.2-1.1) | N=445 | 8.2 (5.9-11.2) | 2.2 (1.2-3.9) | 14.0 (11.1-17.5) | 6.8 (4.9-9.4) | |
| Uruguay | Men | N=237 | 0.7 (0.2-2.8) | 0.6 (0.1-3.6) | N=415 | 8.3 (6.1-11.2) | 2.9 (1.7-5.1) | 13.6 (10.6-17.4) | 17.2 (13.7-21.3) |
| Women | N=573 | 1.9 (1.1-3.3) | 1.1 (0.5-2.6) | N=354 | 6.5 (4.4-9.4) | 4.9 (3.0-8.0) | 22.5 (18.4-27.1) | 11.3 (8.4-15.0) | |
High cardiovascular risk defined as personal history of heart disease or heart attack, personal history of stroke, older age (men aged ≥ 50 years or women aged ≥ 60 years) and personal history of diabetes, or older age and systolic blood pressure ≥ 160 mmHg; therefore, for younger age group (men 35-49 and women 35-59 years old), there are only two components, while for the older group (men >=50 and women >=60) there are four components.